Protein Structure Prediction in Drug Discovery II

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Bioinformatics and Systems Biology".

Deadline for manuscript submissions: 30 May 2024 | Viewed by 2362

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biochemical Sciences “A. Rossi Fanelli”, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
Interests: drug design; molecular docking and virtual screening; protein structure prediction and homology modeling; protein structure and evolution
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Following a very successful first run, we are pleased to announce the launch of a second edition of a Special Issue on “Protein Structure Prediction in Drug Discovery”.

When the results of DeepMind's AlphaFold2 at CASP were announced in 2020, the scientific world was amazed by how effectively it performed; "it will change everything" became the motto for this revolution. As a result, it should come as no surprise that "Protein Structure Prediction" was named Nature's Method of the Year 2021. Structure-based drug discovery (SBDD) is the one area of biology and medicine that is expected to bring the most benefits and make a huge leap as a result of the developments of AlphaFold2 and comparable tools, such as RoseTTAFold. However, since the accuracy of the residues’ conformations at the active sites remains a key limitation in SBDD, as does the inability to guess which conformational state of a protein these tools will predict, it is still necessary to associate and integrate previous physically based models and expert-driven knowledge with new machine learning approaches, as well as experimentally derived structural data.

We encourage articles centered around the promising fields of protein structure prediction and drug development to be published for this timely Special Issue of Biomolecules. New machine learning approaches and tools, as well as developments and applications in previously existing techniques, such as threading and homology modeling, for the protein structure prediction of therapeutic intervention targets, are all areas of interest. Furthermore, scientists working in the broad field of drug discovery are encouraged to submit original research and review articles describing new tools or solutions; the characterization and/or refinement of novel structures; and the design of small molecules, peptides, or peptidomimetics that were discovered using protein structure prediction methods.

Dr. Alessandro Paiardini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • protein structure prediction
  • drug design
  • docking
  • virtual screening
  • drug discovery
  • machine learning
  • alphafold

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 2285 KiB  
Review
Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development
by Xinru Qiu, Han Li, Greg Ver Steeg and Adam Godzik
Biomolecules 2024, 14(3), 339; https://doi.org/10.3390/biom14030339 - 12 Mar 2024
Viewed by 2105
Abstract
Recent advancements in AI-driven technologies, particularly in protein structure prediction, are significantly reshaping the landscape of drug discovery and development. This review focuses on the question of how these technological breakthroughs, exemplified by AlphaFold2, are revolutionizing our understanding of protein structure and function [...] Read more.
Recent advancements in AI-driven technologies, particularly in protein structure prediction, are significantly reshaping the landscape of drug discovery and development. This review focuses on the question of how these technological breakthroughs, exemplified by AlphaFold2, are revolutionizing our understanding of protein structure and function changes underlying cancer and improve our approaches to counter them. By enhancing the precision and speed at which drug targets are identified and drug candidates can be designed and optimized, these technologies are streamlining the entire drug development process. We explore the use of AlphaFold2 in cancer drug development, scrutinizing its efficacy, limitations, and potential challenges. We also compare AlphaFold2 with other algorithms like ESMFold, explaining the diverse methodologies employed in this field and the practical effects of these differences for the application of specific algorithms. Additionally, we discuss the broader applications of these technologies, including the prediction of protein complex structures and the generative AI-driven design of novel proteins. Full article
(This article belongs to the Special Issue Protein Structure Prediction in Drug Discovery II)
Show Figures

Graphical abstract

Back to TopTop